Amur Minerals ( (GB:CRTX) ) has issued an update.
CRISM Therapeutics Corporation announced that its Non-Executive Director, Gerald Beaney, has acquired 20,182 ordinary shares at a price of 9.88 pence per share. This purchase increases Mr. Beaney’s total holdings to 45,182 shares, representing approximately 0.14% of the company’s total issued share capital. The transaction reflects a personal investment by a company director, potentially indicating confidence in the company’s future performance.
More about Amur Minerals
YTD Price Performance: -13.64%
Average Trading Volume: 26,030
Technical Sentiment Signal: Strong Buy
Current Market Cap: £827K
See more data about CRTX stock on TipRanks’ Stock Analysis page.